{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T20:10:33Z","timestamp":1784923833587,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:00:00Z","timestamp":1616544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:00:00Z","timestamp":1616544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Robert Koch-Institut"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Im Rahmen der nationalen Influenzapandemieplanung wurden in Deutschland neben dem Meldewesen gem\u00e4\u00df Infektionsschutzgesetz (IfSG) weitere \u00dcberwachungssysteme etabliert. Ziel dieser Systeme sind die Beschreibung, Analyse und Bewertung der Situation bei akuten respiratorischen Erkrankungen (ARE), die Identifikation der haupts\u00e4chlich zirkulierenden Atemwegserreger und die Beschreibung des zeitlichen Verlaufs. Seit Beginn der COVID-19-Pandemie wurden die Systeme erweitert, um auch Infektionen mit SARS-CoV\u20112 erfassen zu k\u00f6nnen.<\/jats:p><jats:p>In diesem Beitrag werden drei verschiedene Surveillance-Systeme f\u00fcr ARE vorgestellt: GrippeWeb, die Arbeitsgemeinschaft Influenza mit dem SEED<jats:sup>ARE<\/jats:sup>-Modul (Sentinel zur elektronischen Erfassung von Diagnosecodes) und das Krankenhaus-Sentinel ICOSARI (ICD-10-code-basierte Krankenhaus-Surveillance schwerer akuter respiratorischer Infektionen). Mit diesen Systemen k\u00f6nnen ARE auf Bev\u00f6lkerungsebene, im ambulanten und im station\u00e4ren Bereich \u00fcberwacht werden. Zusammen mit dem Monitoring der Mortalit\u00e4t liefern sie wichtige Hinweise zur H\u00e4ufigkeit verschieden schwerer Krankheitsverl\u00e4ufe in der Bev\u00f6lkerung. Um die Systeme f\u00fcr SARS-CoV\u20112 zu erweitern, waren nur wenige Anpassungen notwendig.<\/jats:p><jats:p>Da die Falldefinitionen f\u00fcr ARE nicht ge\u00e4ndert wurden, k\u00f6nnen in den beschriebenen Systemen historische Zeitreihen zum Vergleich herangezogen werden. Alle Systeme sind so aufgebaut, dass stabile und etablierte Bezugsgr\u00f6\u00dfen f\u00fcr die Berechnung von w\u00f6chentlichen Anteilen und Raten zur Verf\u00fcgung stehen. Dies ist eine wichtige Erg\u00e4nzung zum Meldewesen gem\u00e4\u00df IfSG, welches stark von Testkapazit\u00e4ten und -strategien sowie ver\u00e4nderten Falldefinitionen abh\u00e4ngt. Die Surveillance-Systeme haben sich in der COVID-19-Pandemie auch im internationalen Vergleich als praktikabel und effizient erwiesen.<\/jats:p>","DOI":"10.1007\/s00103-021-03303-2","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T12:02:40Z","timestamp":1616587360000},"page":"395-402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["\u00dcberwachung von COVID-19 durch Erweiterung der etablierten Surveillance f\u00fcr Atemwegsinfektionen","Monitoring of COVID-19 by extending existing surveillance for acute respiratory infections"],"prefix":"10.1007","volume":"64","author":[{"given":"Luise","family":"Goerlitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Tolksdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Buchholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Prahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Preu\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"an der Heiden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"D\u00fcrrwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Nitsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Buda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,24]]},"reference":[{"key":"3303_CR1","volume-title":"Nationaler Pandemieplan Teil I","author":"Robert Koch-Institut","year":"2017","unstructured":"Robert Koch-Institut (2017) Nationaler Pandemieplan Teil I. Robert Koch-Institut, Berlin"},{"key":"3303_CR2","unstructured":"World Health Organization (2017) Pandemic influenza risk management. A WHO guide to inform & harmonize national & international pandemic preparedness and response. WHO publication. p\u00a062. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/259893\/WHO-WHE-IHM-GIP-2017.1-eng.pdf. Zugegriffen: 4. Febr. 2021"},{"key":"3303_CR3","unstructured":"World Health Organization (2017) WHO guidance for surveillance during an influenza pandemic: 2017 update. WHO Publication. p\u00a059. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/259886\/9789241513333-eng.pdf. Zugegriffen: 4. Febr. 2021"},{"key":"3303_CR4","unstructured":"World Health Organization (2018) Surveillance for human infection with Middle East respiratory syndrome coronavirus (MERS \u2013 CoV) Interim guidance. WHO Publication. https:\/\/www.who.int\/publications\/i\/item\/10665-177869. Zugegriffen: 4. Febr. 2021"},{"key":"3303_CR5","unstructured":"World Health Organization Regional Office for the Eastern Mediterranean Public Health Measures for Scaling up National Preparedness\u2013Middle East Respiratory Syndrome (MERS) WHO EMRO publication. https:\/\/applications.emro.who.int\/docs\/EMROPub_2018_EN_16794.pdf. Zugegriffen: 4. Febr. 2021"},{"key":"3303_CR6","volume-title":"Nationaler Pandemieplan \u2013 Ver\u00f6ffentlichung des wissenschaftlichen Teils","author":"Robert Koch-Institut","year":"2016","unstructured":"Robert Koch-Institut (2016) Nationaler Pandemieplan \u2013 Ver\u00f6ffentlichung des wissenschaftlichen Teils. Robert Koch-Institut, Epidemiologie und Gesundheitsberichterstattung, Berlin"},{"key":"3303_CR7","volume-title":"Zeitliche Trends in der Inzidenz und Sterblichkeit respiratorischer Krankheiten von hoher Public-Health-Relevanz in Deutschland","author":"H Steppuhn","year":"2017","unstructured":"Steppuhn\u00a0H, Buda\u00a0S, Wienecke\u00a0A et al (2017) Zeitliche Trends in der Inzidenz und Sterblichkeit respiratorischer Krankheiten von hoher Public-Health-Relevanz in Deutschland. Robert Koch-Institut, Epidemiologie und Gesundheitsberichterstattung, Berlin"},{"key":"3303_CR8","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s00103-018-2758-3","volume":"61","author":"M Diercke","year":"2019","unstructured":"Diercke\u00a0M, Beermann\u00a0S, Tolksdorf\u00a0K, Buda\u00a0S, Kirchner\u00a0G (2019) Infektionskrankheiten und ihre Codierung. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 61:806\u2013811","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"3303_CR9","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES2014.19.4.20684","volume-title":"Internet-based syndromic monitoring of acute respiratory illness in the general population of Germany, weeks 35\/2011 to 34\/2012","author":"C Bayer","year":"2014","unstructured":"Bayer\u00a0C, Remschmidt\u00a0C, Heiden\u00a0MD et al (2014) Internet-based syndromic monitoring of acute respiratory illness in the general population of Germany, weeks 35\/2011 to 34\/2012. Robert Koch-Institut, Infektionsepidemiologie, Berlin"},{"key":"3303_CR10","first-page":"1","volume":"2019","author":"JM Haussig","year":"2019","unstructured":"Haussig\u00a0JM, Targosz\u00a0A, Engelhart\u00a0S et al (2019) Feasibility study for the use of self-collected nasal swabs to identify pathogens among participants of a\u00a0population-based surveillance system for acute respiratory infections (GrippeWeb-Plus)\u2014Germany, 2016. Influenza Other Respi Viruses 2019:1\u201312","journal-title":"Influenza Other Respi Viruses"},{"key":"3303_CR11","first-page":"7","volume":"2020","author":"U Buchholz","year":"2020","unstructured":"Buchholz\u00a0U, Buda\u00a0S, Prahm\u00a0K (2020) Abrupter R\u00fcckgang der Raten an Atemwegserkrankungen in der deutschen Bev\u00f6lkerung. Epidemiol Bull 2020:7\u20139","journal-title":"Epidemiol Bull"},{"key":"3303_CR12","volume-title":"GrippeWeb als wichtiges Instrument in der Vorbereitung und Bew\u00e4ltigung einer zuk\u00fcnftigen Pandemie","author":"U Buchholz","year":"2017","unstructured":"Buchholz\u00a0U, Gau\u00a0P, Buda\u00a0S, Prahm\u00a0K (2017) GrippeWeb als wichtiges Instrument in der Vorbereitung und Bew\u00e4ltigung einer zuk\u00fcnftigen Pandemie. Robert Koch-Institut, Epidemiologie und Gesundheitsberichterstattung, Berlin"},{"key":"3303_CR13","unstructured":"Deutsches Jugendinstitut (2020) Corona-KiTa-Studie. https:\/\/corona-kita-studie.de\/. Zugegriffen: 4. Febr. 2021"},{"key":"3303_CR14","unstructured":"Robert Koch Institut (2020) Arbeitgemeinschaft Influenza. https:\/\/influenza.rki.de\/Arbeitsgemeinschaft.aspx. Zugegriffen: 4. Febr. 2021"},{"issue":"Suppl 1","key":"3303_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/jech.49.Suppl_1.9","volume":"49","author":"J Szecsenyi","year":"1995","unstructured":"Szecsenyi\u00a0J, Uphoff\u00a0H, Ley\u00a0S, Brede\u00a0HD (1995) Influenza surveillance: experiences from establishing a\u00a0sentinel surveillance system in Germany. J\u00a0Epidemiol Community Health 49(Suppl 1):9\u201313","journal-title":"J Epidemiol Community Health"},{"key":"3303_CR16","unstructured":"Robert Koch Institut (2020) Nationales Referenzzentrum f\u00fcr Influenzaviren. https:\/\/www.rki.de\/DE\/Content\/Infekt\/NRZ\/Influenza\/influenza_node.html. Zugegriffen: 4. Febr. 2021"},{"key":"3303_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00103-016-2454-0","volume-title":"Evaluation einer ICD-10-basierten elektronischen Surveillance akuter respiratorischer Erkrankungen (SEEDARE) in Deutschland","author":"K K\u00f6pke","year":"2016","unstructured":"K\u00f6pke\u00a0K, Prahm\u00a0K, Buda\u00a0S, Haas\u00a0W (2016) Evaluation einer ICD-10-basierten elektronischen Surveillance akuter respiratorischer Erkrankungen (SEEDARE) in Deutschland. Robert Koch-Institut, Infektionsepidemiologie, Berlin"},{"key":"3303_CR18","first-page":"3","volume":"2020","author":"L Goerlitz","year":"2020","unstructured":"Goerlitz\u00a0L, D\u00fcrrwald\u00a0R, Der Heiden\u00a0AM et al (2020) Erste Ergebnisse zum Verlauf der Grippewelle in der Saison 2019\/20: Mit 11\u00a0Wochen vergleichsweise k\u00fcrzere Dauer und eine moderate Anzahl an Influenza-bedingten Arztbesuchen. Epidemiol Bull 2020:3\u20136","journal-title":"Epidemiol Bull"},{"key":"3303_CR19","doi-asserted-by":"publisher","unstructured":"Wedde MDS, Biere B, K\u00f6ndgen S, Reiche J, Oh DY, D\u00fcrrwald R (2020) Virologische Analysen in der Infuenzasaison 2019\/20. Epidemiol Bull 45:3\u20136. https:\/\/doi.org\/10.25646\/7159","DOI":"10.25646\/7159"},{"key":"3303_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-017-4515-1","volume-title":"Establishing an ICD-10 code based SARI-surveillance in Germany\u2014description of the system and first results from five recent influenza seasons","author":"S Buda","year":"2017","unstructured":"Buda\u00a0S, Tolksdorf\u00a0K, Schuler\u00a0E, Kuhlen\u00a0R, Haas\u00a0W (2017) Establishing an ICD-10 code based SARI-surveillance in Germany\u2014description of the system and first results from five recent influenza seasons. Robert Koch-Institut, Infektionsepidemiologie, Berlin"},{"key":"3303_CR21","unstructured":"European Centre for Disease Prevention and Control (2020) Strategies for the surveillance of COVID-19. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/COVID-19-surveillance-strategy-9-Apr-2020.pdf. Zugegriffen: 4. Febr. 2021"},{"key":"3303_CR22","doi-asserted-by":"publisher","unstructured":"Tolksdorf K, Buda S, Schuler E, Wieler LH, Haas W (2020) Influenza-associated pneumonia as reference to assess seriousness of coronavirus disease (COVID-19). Euro Surveill 25(11):pii=2000258. https:\/\/doi.org\/10.2807\/1560-7917.ES.2020.25.11.2000258","DOI":"10.2807\/1560-7917.ES.2020.25.11.2000258"},{"key":"3303_CR23","doi-asserted-by":"publisher","unstructured":"Tolksdorf K, Buda S, Schuler E, Wieler LH, Haas W (2020) Eine h\u00f6here Letalit\u00e4t und lange Beatmungsdauer unterscheiden COVID-19 von schwer verlaufenden Atemwegsinfektionen in Grippewellen. Epid Bull 41:3\u201310. https:\/\/doi.org\/10.25646\/7111","DOI":"10.25646\/7111"},{"key":"3303_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.10.037","author":"L Staadegaard","year":"2020","unstructured":"Staadegaard\u00a0L, Taylor\u00a0RJ, Spreeuwenberg\u00a0P, Caini\u00a0S, Simonsen\u00a0L, Paget\u00a0J (2020) Monitoring the mortality impact of COVID-19 in Europe: what can be learned from 2009 influenza H1N1p mortality studies? Int J Infect Dis. https:\/\/doi.org\/10.1016\/j.ijid.2020.10.037","journal-title":"Int J Infect Dis"},{"key":"3303_CR25","doi-asserted-by":"publisher","unstructured":"Vestergaard LS, Nielsen J, Richter L et al (2020) Excess all-cause mortality during the COVID-19 pandemic in Europe\u2014preliminary pooled estimates from the EuroMOMO network, March to April 2020. Euro Surveill 25(26):pii=2001214. https:\/\/doi.org\/10.2807\/1560-7917.ES.2020.25.26.2001214","DOI":"10.2807\/1560-7917.ES.2020.25.26.2001214"},{"key":"3303_CR26","unstructured":"Euromomo (2020) European network for monitoring of excess mortality for public health action. https:\/\/www.euromomo.eu\/graphs-and-maps. Zugegriffen: 4. Febr. 2021"},{"key":"3303_CR27","unstructured":"Statistisches Bundesamt (2020) Sterbef\u00e4lle und Lebenserwartung Sonderauswertung zu Sterbefallzahlen des Jahres 2020. https:\/\/www.destatis.de\/DE\/Themen\/Gesellschaft-Umwelt\/Bevoelkerung\/Sterbefaelle-Lebenserwartung\/sterbefallzahlen.html. Zugegriffen: 4. Febr. 2021"},{"key":"3303_CR28","first-page":"3","volume":"2020","author":"NK K\u00fcpke","year":"2020","unstructured":"K\u00fcpke\u00a0NK, Matysiak-Klose\u00a0D, Siedler\u00a0A, Wichmann\u00a0O, Diercke\u00a0M (2020) Gesetz f\u00fcr den Schutz vor Masern und zur St\u00e4rkung der Impfpr\u00e4vention (Masernschutzgesetz). Epidemiol Bull 2020:3\u20135","journal-title":"Epidemiol Bull"},{"key":"3303_CR29","unstructured":"Robert Koch Institut (2020) Projekt COSIK: Pilotphase COVID-19-Surveillance im Krankenhaus. https:\/\/www.rki.de\/DE\/Content\/Institut\/OrgEinheiten\/Abt3\/FG37\/cosik.html. Zugegriffen: 4. Febr. 2021"},{"key":"3303_CR30","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.1111\/j.1750-2659.2012.00404.x","volume":"6","author":"C Adlhoch","year":"2012","unstructured":"Adlhoch\u00a0C, Wadl\u00a0M, Behnke\u00a0M, Pe\u00f1a Diaz\u00a0LA, Clausmeyer\u00a0J, Eckmanns\u00a0T (2012) Pandemic influenza A(H1)pdm09 in hospitals and intensive care units\u2014results from a\u00a0new hospital surveillance, Germany 2009\/2010. Influenza Other Respir Viruses 6:e162\u2013e168","journal-title":"Influenza Other Respir Viruses"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-021-03303-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00103-021-03303-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-021-03303-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T11:18:24Z","timestamp":1619003904000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00103-021-03303-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,24]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["3303"],"URL":"https:\/\/doi.org\/10.1007\/s00103-021-03303-2","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,24]]},"assertion":[{"value":"30 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"L.\u00a0Goerlitz, K.\u00a0Tolksdorf, U.\u00a0Buchholz, K.\u00a0Prahm, U.\u00a0Preu\u00df, M.\u00a0an der Heiden, T.\u00a0Wolff, R.\u00a0D\u00fcrrwald, A.\u00a0Nitsche, J.\u00a0Michel, W.\u00a0Haas und S.\u00a0Buda geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}